Nov 10 (Reuters) - Futures for Canada's main stock index were flat on Tuesday as worries over the short-term economic impact of rising coronavirus cases worldwide overshadowed optimism around positive data from a late-stage COVID-19 vaccine trial.
U.S. drugmaker Pfizer (NYSE:PFE) PFE.N said on Monday its experimental COVID-19 vaccine was more than 90% effective, while Canadian drug developer Medicago said on Tuesday its COVID-19 vaccine triggered an immune response in an early-stage trial. futures on the S&P/TSX index SXFc1 were flat at 7:30 a.m. ET.
The Toronto Stock Exchange's S&P/TSX composite index .GSPTSE ended 1.18% higher at 16,475.86 on Monday. .TO
Dow Jones Industrial Average e-mini futures 1YMc1 were up 0.65% on Tuesday. S&P 500 e-mini futures ESc1 dropped 0.27% and Nasdaq 100 e-mini futures NQc1 fell 1.7%. .N
TOP STORIES TOP/CAN
Canadian food producer Premium Brands Holdings Corp PBH.TO and a coalition of Mi'kmaq First Nations said on Monday they would buy Clearwater Seafoods Inc CLR.TO , one of the largest shellfish distributors in the country, in a deal valued at about C$1 billion, including debt. prices rose on Tuesday as hopes that a COVID-19 vaccine could be on the horizon outweighed the expected negative impact on fuel demand of new lockdowns to curb the virus. AT 7:30 a.m. ET
Gold futures GCc2 : $1,876.7; +1.22% GOL/
US crude CLc1 : $40.58; +0.69% O/R
Brent crude LCOc1 : $42.81; +0.97% O/R
FOR CANADIAN MARKETS NEWS, CLICK ON CODES:
TSX market report .TO
Canadian dollar and bonds report CAD/ CA/
Reuters global stocks poll for Canada EQUITYPOLL1 EPOLL/CA
Canadian markets directory CANADA ($1= C$1.30)